Biggest News Aggregation in the World
📰 Marcus News

Page 40 - Marcus News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Marcus. Real-time updates on events, politics, business and more.

Short Interest in The Marcus Co. (NYSE:MCS) Grows By 6.4%

The Marcus Co. (NYSE:MCS – Get Free Report) saw a significant increase in short interest in January. As of January 31st, there was short interest totalling 4,140,000 shares, an increase of 6.4% from the January 15th total of 3,890,000 shares. Approximately 17.7% of the company’s shares are short sold. Based on an average daily volume […]
United States Marcus Company Profile Group Plc Marcus Co Barclays Plc Vanguard Group Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of "Moderate Buy" by Analysts

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight analysts that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among […]
United States Robertc Goeltz Cantor Fitzgerald Morgan Stanley Securities Exchange Commission Arcus Biosciences Company Profile

Marcus Rezak comes to Roots Music Project on March 9, 2024

Marcus Rezak comes to Roots Music Project on March 9, 2024. Known as a Master of Jazz improvisation and a seasoned artist of the sit-in, Rezak is a frequent call among bands and musicians. Rezak’s 2018 debut as a bandleader saw him collaborating alongside Kris Meyers and Joel Cummins of Umphrey’s McGee, Arthur Barrow of Frank Zappa’s band, and legendary saxophonist Bill Evans.
United States Joel Cummins Kris Meyers Bill Evans Mike Willis Frank Zappa

Arcus Biosciences (NYSE:RCUS) PT Lowered to $42.00 at Mizuho

Arcus Biosciences (NYSE:RCUS – Free Report) had its price objective lowered by Mizuho from $51.00 to $42.00 in a research note released on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other equities research analysts also recently weighed in on RCUS. Morgan Stanley dropped their price target […]
United States Robertc Goeltz Boxer Capital Gilead Sciences Inc Cantor Fitzgerald Arcus Biosciences Inc
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science